Axsome Therapeutics, Inc. (AXSM)

Number of records: 32
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
17-Mar-22 7:05 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 15-Mar-22Option Exercise 3,496$1.30$4,544.80< 1%
426.53K to 430.02K
23-Nov-21 7:30 AM
View: 
Jeffs Roger
Director
Axsome Therapeutics, Inc. (AXSM) 19-Nov-21Market Purchase 3,950$37.30$147,350.002%
163.72K to 167.67K
(1%)
22-Nov-21 7:31 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 18-Nov-21Market Purchase 527$35.50$18,708.501%
41.32K to 41.85K
< 1%
22-Nov-21 7:30 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 18-Nov-21Market Purchase 1,430$35.09$50,180.70< 1%
425.1K to 426.53K
2%
22-Nov-21 7:31 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 18-Nov-21Market Purchase 428$34.97$14,967.501%
41.85K to 42.28K
2%
19-Nov-21 7:30 AM
View: 
Saad Mark E
Director
Axsome Therapeutics, Inc. (AXSM) 17-Nov-21Market Purchase 3,000$34.53$103,597.0044%
6.8K to 9.8K
3%
19-Nov-21 7:30 AM
View: 
Saad Mark E
Director
Axsome Therapeutics, Inc. (AXSM) 17-Nov-21Market Purchase 300$34.42$10,324.503%
9.8K to 10.1K
3%
13-May-21 7:05 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 12-May-21Market Purchase 500$58.15$29,075.00< 1%
424.6K to 425.1K
(2%)
20-Aug-20 8:43 PM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 19-Aug-20Gift 397,998----97%
408.8K to 806.8K
20-Aug-20 8:43 PM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 19-Aug-20Gift 397,998----(49%)
806.8K to 408.8K
30-Jun-20 8:19 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 29-Jun-20Market Purchase 777$76.64$59,549.302%
40.5K to 41.28K
30-Jun-20 8:20 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 29-Jun-20Market Purchase 650$78.50$51,025.00< 1%
408.15K to 408.8K
14-Jan-20 4:08 PM
View: 
Jeffs Roger
Director
Axsome Therapeutics, Inc. (AXSM) 10-Jan-20Option Exercise 60,186$10.46$629,756.0058%
103.53K to 163.72K
30-Sep-19 7:16 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 26-Sep-19Market Purchase 2,180$24.80$54,064.006%
38.32K to 40.5K
(7%)
05-Jul-19 7:00 AM
View: 
Jeffs Roger
Director
Axsome Therapeutics, Inc. (AXSM) 03-Jul-19Option Exercise 56,620$3.04$172,178.00121%
46.91K to 103.53K
27-Jun-19 7:18 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 26-Jun-19Market Purchase 15,800$23.10$364,980.002%
658.15K to 673.95K
(< 1%)
27-Jun-19 7:18 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 25-Jun-19Market Purchase 400$23.25$9,300.00< 1%
657.75K to 658.15K
(1%)
12-Jun-19 7:00 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 11-Jun-19Market Purchase 1,920$20.80$39,936.00100%
0 to 1.92K
< 1%
24-May-19 7:19 AM
View: 
Saad Mark E
Director
Axsome Therapeutics, Inc. (AXSM) 23-May-19Market Purchase 3,500$22.33$78,155.00100%
3.5K to 7.0K
6%
15-May-19 7:21 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 13-May-19Market Purchase 4,650$21.44$99,696.00< 1%
653.1K to 657.75K
1%
21-Mar-19 7:05 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 19-Mar-19Market Purchase 60$12.69$761.40< 1%
31.0K to 31.06K
(5%)
21-Mar-19 7:05 AM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 19-Mar-19Market Purchase 5,100$12.18$62,118.00< 1%
648.0K to 653.1K
(1%)
21-Mar-19 7:05 AM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 19-Mar-19Market Purchase 5,340$12.58$67,177.2017%
31.06K to 36.4K
(5%)
20-Jun-18 5:00 PM
View: 
Pizzie Nick
Chief Financial Officer
Axsome Therapeutics, Inc. (AXSM) 19-Jun-18Market Purchase 31,000$3.10$96,080.00100%
0 to 31.0K
206%
30-Mar-17 4:31 PM
View: 
Jeffs Roger
Director
Axsome Therapeutics, Inc. (AXSM) 29-Mar-17Option Exercise 42,538$4.73$201,163.00973%
4.37K to 46.91K
24-Dec-15 1:02 PM
View: 
Kaye Randall
Chief Medical Officer
Axsome Therapeutics, Inc. (AXSM) 23-Dec-15Market Purchase 1,000$9.03$9,026.0020%
5.02K to 6.02K
7%
24-Nov-15 4:25 PM
View: 
Coleman Mark
Director
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 564,948$5.71$3,224,170.00680%
83.05K to 648.0K
24-Nov-15 4:26 PM
View: 
Ames Constance
Vice President, Finance
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 4,358$5.94$25,886.50100%
0 to 4.36K
24-Nov-15 4:24 PM
View: 
Saad Mark E
Director
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 3,502$5.94$20,801.90100%
0 to 3.5K
24-Nov-15 4:24 PM
View: 
Tabuteau Herriot
Chief Executive Officer
Director
10% Owner
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 7,229$5.94$42,940.30< 1%
7.34M to 7.35M
24-Nov-15 4:26 PM
View: 
Kaye Randall
Chief Medical Officer
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 5,022$5.40$27,118.80100%
0 to 5.02K
24-Nov-15 4:25 PM
View: 
Jeffs Roger
Director
Axsome Therapeutics, Inc. (AXSM) 24-Nov-15Conversion 4,374$5.94$25,981.60100%
0 to 4.37K